Genera Life

Imatinib, Geftinib, Temozolomide, Altretamine, Zoledronic Acid, Bortezomib. Clinical Trials, HCV, HIV Antigens, Neurocysticercosis Kit, Transplantation Preservatives, Clinical Packaging, Iron sucrose, Linezolid, Meprobamate, Oxyresveratrol Cream, Contract Manufacturing-Injections,Tabs,Caps(European GMP, Licensing Dossiers/MAs, Cephalosporins

Activity:

- Clinical Trials
- Contract Manufacturing
- Licensing & Business Development

Product / Technology type(s) covered:

- API / chemicals
- Diagnostics
- Drug delivery
- Generics
- FP (finished products)
- Proteins

Therapeutic targets:

- Cancer
- Infectious Diseases
- Transplant

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Europe , North America , Central/South America , Africa

c. Countries active: UK, Germany, Netherlands, Poland, USA

Corporate data:

Number of Employees: 10

Turnover:

Amount:	Year:	Currency:
1 Mn	2006	Euro

Year founded: 2006

Partners / Alliances: Genera Life Sciences, SPR Pharma, Polestar Ventures, Indtek International, The Pharma Network, USA Delfarma, Poland